000 01472 a2200397 4500
005 20250513072434.0
264 0 _c19930805
008 199308s 0 0 eng d
022 _a1046-6673
024 7 _a10.1681/ASN.V3101672
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaupke, C J
245 0 0 _aEffect of recombinant human erythropoietin on platelet production in dialysis patients.
_h[electronic resource]
260 _bJournal of the American Society of Nephrology : JASN
_cApr 1993
300 _a1672-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAnemia
_xblood
650 0 4 _aCatheters, Indwelling
650 0 4 _aDouble-Blind Method
650 0 4 _aErythropoietin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHematopoiesis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlatelet Count
_xdrug effects
650 0 4 _aRecombinant Proteins
_xadverse effects
650 0 4 _aRegression Analysis
650 0 4 _aRenal Dialysis
650 0 4 _aThrombosis
_xchemically induced
700 1 _aButler, G C
700 1 _aVaziri, N D
773 0 _tJournal of the American Society of Nephrology : JASN
_gvol. 3
_gno. 10
_gp. 1672-9
856 4 0 _uhttps://doi.org/10.1681/ASN.V3101672
_zAvailable from publisher's website
999 _c8317961
_d8317961